Review article · 2022 · Open access
Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature
Alzheimer s & Dementia, 18(9), 1687–1693 · Published 25 February 2022 · DOI 10.1002/alz.12618
In brief
“Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature” is a 2022 review article by Henrik Zetterberg, published in Alzheimer s & Dementia. OpenAlex counts 61 citations as of 18 November 2026, which puts it in the top 2% of works published in 2022 by citations. It is open access: the full text is free to read at PubMed Central.
- Citations
- 61
- Most cited in
- 2024 (22)
- Field-weighted impact
- 1.71
- References
- 74
- Authors
- 1
Abstract
The past few years have seen an explosion in sensitive and specific assays for cerebrospinal fluid (CSF) and blood biomarkers for Alzheimer's disease (AD) and related disorders, as well as some novel assays based on pathological seed-induced protein misfolding in patient samples. Here, I review this exciting field that promises to transform dementia diagnostics and disease monitoring. I discuss data on biomarkers for amyloid beta (Aβ) and tau pathology, neurodegeneration, and glial activation, mention the most promising biomarkers for α-synuclein and TDP-43 pathology, and highlight the need for further research into common co-pathologies. Finally, I consider practical aspects of blood-based biomarker-supported AD diagnostics and emphasize the importance of biomarker interpretation in a full clinical context.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Zetterberg, H. (2022). Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature. Alzheimer s & Dementia, 18(9), 1687–1693. https://doi.org/10.1002/alz.12618
MLA 9
Zetterberg, Henrik. “Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature.” Alzheimer s & Dementia, vol. 18, no. 9, 2022, pp. 1687–1693. https://doi.org/10.1002/alz.12618.
Chicago
Zetterberg, Henrik. 2022. “Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature.” Alzheimer s & Dementia 18 (9): 1687–1693. https://doi.org/10.1002/alz.12618.
Harvard
Zetterberg, H. (2022) ‘Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature’, Alzheimer s & Dementia, 18(9), pp. 1687–1693. doi:10.1002/alz.12618.
IEEE
H. Zetterberg, “Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature,” Alzheimer s & Dementia, vol. 18, no. 9, pp. 1687–1693, 2022, doi: 10.1002/alz.12618.
BibTeX
@article{zetterberg2022biofluid,
title = {{Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature}},
author = {Zetterberg, Henrik},
journal = {Alzheimer s \& Dementia},
year = {2022},
volume = {18},
number = {9},
pages = {1687--1693},
doi = {10.1002/alz.12618},
url = {https://doi.org/10.1002/alz.12618}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 6 | |
| 2023 | 14 | |
| 2024 | 22 | |
| 2025 | 11 | |
| 2026 | 8 |
Its field-weighted citation impact is 1.71: it has been cited 1.71 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Alzheimer's disease
- biomarkers
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Zetterberg, H. (2022). Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature. Alzheimer s & Dementia, 18(9), 1687–1693. https://doi.org/10.1002/alz.12618
How many times has this paper been cited?
61 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at PubMed Central: sign in and open the full text from this page.
Who wrote this paper?
Henrik Zetterberg.
What is the DOI of this paper?
10.1002/alz.12618, permanently at https://doi.org/10.1002/alz.12618. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.